Sinopep-Allsino Bio Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 13.81% vs 36.31% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 21.03% vs 135.45% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "478.90",
          "val2": "420.80",
          "chgp": "13.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "161.00",
          "val2": "197.90",
          "chgp": "-18.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.30",
          "val2": "9.20",
          "chgp": "98.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "143.90",
          "val2": "118.90",
          "chgp": "21.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "336.20%",
          "val2": "332.00%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 56.50% vs 60.79% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 141.57% vs 34.77% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,615.60",
          "val2": "1,032.30",
          "chgp": "56.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "670.10",
          "val2": "323.90",
          "chgp": "106.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "35.10",
          "val2": "16.40",
          "chgp": "114.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "0.30",
          "chgp": "-1,033.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "399.80",
          "val2": "165.50",
          "chgp": "141.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "280.50%",
          "val2": "178.00%",
          "chgp": "10.25%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

478.90

420.80

13.81%

Operating Profit (PBDIT) excl Other Income

161.00

197.90

-18.65%

Interest

18.30

9.20

98.91%

Exceptional Items

0.00

-1.60

100.00%

Consolidate Net Profit

143.90

118.90

21.03%

Operating Profit Margin (Excl OI)

336.20%

332.00%

0.42%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 13.81% vs 36.31% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 21.03% vs 135.45% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,615.60

1,032.30

56.50%

Operating Profit (PBDIT) excl Other Income

670.10

323.90

106.88%

Interest

35.10

16.40

114.02%

Exceptional Items

-2.80

0.30

-1,033.33%

Consolidate Net Profit

399.80

165.50

141.57%

Operating Profit Margin (Excl OI)

280.50%

178.00%

10.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 56.50% vs 60.79% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 141.57% vs 34.77% in Dec 2023

All Annual Results